Italia markets open in 6 hours 13 minutes

SWTX Sep 2024 25.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,90000,0000 (0,00%)
In data: 09:30AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,9000
Aperto0,9000
Denaro0,0000
Domanda4,7000
Prezzo d'esercizio25,00
Scadenza2024-09-20
Min-Max giorno0,9000 - 0,9000
Contratto - Min-MaxN/D
Volume1
Open Interest16
  • GlobeNewswire

    SpringWorks Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

    – Presented additional Phase 3 DeFi data at ASCO demonstrating clinically significant reductions in pain and substantial reductions in tumor volume and T2 hyperintensity with nirogacestat treatment – – Completed enrollment of Phase 2 trial evaluating nirogacestat in patients with ovarian granulosa cell tumors – – Highlighted encouraging Phase 1 and 2 clinical data from emerging pipeline programs at AACR and EHA – STAMFORD, Conn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (